To further investigate the therapeutic vulnerability of the pharmacological inhibition of DNA‐PKcs on TRIM24‐induced Ep‐GBM‐like tumor progression, we first assessed the effects of NU7441 on NHA/HRasV12/TRIM24 cells. The gene discussed is PRKDC; the disease is glioblastoma.